The Food and Drug Administration (FDA) on Wednesday approved the first gene therapy treatment that could offer a permanent cure for patients who suffer from a rare blood disorder, which the manufacturer priced at $2.8 million per patient. The cost would make the therapy one of the most expensive treatments of all time. The therapy was developed by bluebird bio […]
